AJM online Clinical research study| Volume 126, ISSUE 12, P1142.e9-1142.e14, December 2013

Antihistamine-resistant Angioedema in Women with Negative Family History: Estrogens and F12 Gene Mutations



      In women with sporadic recurrent angioedema with an unknown cause who are unresponsive to antihistamines and have normal C1 inhibitor activity and a negative family history of angioedema, it is unclear whether they have idiopathic angioedema or hereditary angioedema with normal C1 inhibitor, and what impact exogenous estrogens have on their angioedema.


      A cohort of 147 women was analyzed for F12 exon 9 mutations and for the influence of oral contraceptives, hormonal replacement therapy, and pregnancy on their angioedema.


      A total of 142 women had idiopathic angioedema unresponsive to antihistamines. Five women had an F12 mutation and thereby hereditary angioedema with F12 mutations. Among the women with idiopathic angioedema, 63 had never taken estrogens. There was no estrogen impact in 42 women, a moderate impact in 15 women, and a severe impact in 22 women. The type and dose of estrogens did not differ in women with and without an estrogen impact. In 5 women, idiopathic angioedema disappeared after desogestrel use. Among the 5 women with hereditary angioedema with F12 mutations, angioedema symptoms occurred during 4 pregnancies, whereas no symptoms occurred during any of the 58 pregnancies in women with idiopathic angioedema.


      Women with recurrent angioedema unresponsive to antihistamines may have idiopathic angioedema or, more rarely, hereditary angioedema with F12 mutations. Both conditions may be provoked or aggravated by exogenous estrogens. In idiopathic angioedema, treatment with progestins may be helpful.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Zingale L.C.
        • Beltrami L.
        • Zanichelli A.
        • et al.
        Angioedema without urticaria: a large clinical survey.
        CMAJ. 2006; 175: 1065-1070
        • Bork K.
        • Barnstedt S.E.
        • Koch P.
        • Traupe H.
        Hereditary angioedema with normal C1-inhibitor activity in women.
        Lancet. 2000; 356: 213-217
        • Binkley K.E.
        • Davis 3rd, A.
        Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema.
        J Allergy Clin Immunol. 2000; 106: 546-550
        • Dewald G.
        • Bork K.
        Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor.
        Biochem Biophys Res Commun. 2006; 343: 1286-1289
        • Bork K.
        • Wulff K.
        • Hardt J.
        • Witzke G.
        • Staubach P.
        Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy.
        J Allergy Clin Immunol. 2009; 124: 129-134
        • Bork K.
        • Wulff K.
        • Meinke P.
        • Wagner N.
        • Hardt J.
        • Witzke G.
        A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor.
        Clin Immunol. 2011; 141: 31-35
        • Vitrat-Hincky V.
        • Gompel A.
        • Dumestre-Perard C.
        • et al.
        Type III hereditary angio-oedema: clinical and biological features in a French cohort.
        Allergy. 2010; 65: 1331-1336
        • Marcos C.
        • Lopez Lera A.
        • Varela S.
        • Linares T.
        • Alvarez-Eire M.G.
        • Lopez-Trascasa M.
        Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families.
        Ann Allergy Asthma Immunol. 2012; 109: 195-200.e2
        • Bork K.
        • Fischer B.
        • Dewald G.
        Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy.
        Am J Med. 2003; 114: 294-298
        • Caballero T.
        • Farkas H.
        • Bouillet L.
        • et al.
        International consensus and practical guidelines on the gynaecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.
        J Allergy Clin Immunol. 2012; 129: 308-320
        • Farsetti A.
        • Misiti S.
        • Citarella F.
        • et al.
        Molecular basis of estrogen regulation of Hageman factor XII gene expression.
        Endocrinology. 1995; 136: 5076-5083
        • Zuraw B.L.
        • Bork K.
        • Binkley K.
        • et al.
        Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel.
        Allergy Asthma Proc. 2012; 33: 145-156
        • Bork K.
        • Gul D.
        • Hardt J.
        • Dewald G.
        Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course.
        Am J Med. 2007; 120: 987-992

      Linked Article